• Complex
  • Title
  • Keyword
  • Abstract
  • Scholars
  • Journal
  • ISSN
  • Conference
成果搜索

author:

Wang, Ying (Wang, Ying.) [1] | Zheng, Ke (Zheng, Ke.) [2] | Xuan, Guangshan (Xuan, Guangshan.) [3] | Huang, Mingdong (Huang, Mingdong.) [4] (Scholars:黄明东) | Xue, Jinping (Xue, Jinping.) [5] (Scholars:薛金萍)

Indexed by:

Scopus SCIE

Abstract:

Purpose: Zinc phthalocyanine (ZnPc) has been applied widely in photodynamic therapy (PDT) with high ROS-production capacity and intense absorption in the near-infrared region. However, weak tumor targeting and the aggregation tendency of ZnPc seriously affect the therapeutic effect of PDT. Therefore, overcoming the aggregation of ZnPc and enhancing its antitumor effect were the purpose of this study. Methods: In this study, we first found that the aggregation behaviors of the photosensitizer ZnPc(TAP)(4), ZnPc substituted by tertiary amine groups, were regulated finely by pH and that ZnPc(TAP)(4) could be disaggregated gradually as the pH descended. ZnPc(TAP)(4) and human serum albumin (HSA) molecules were assembled into nanoparticles (NPs) for tumor targeting. Meanwhile, the chemotherapy drug paclitaxel (Ptx) was loaded into HSA NPs together with ZnPc(TAP)(4) for dual antitumor effects. HSA NPs loading both ZnPc(TAP)(4) and Ptx (NP-ZnPc[TAP](4)-Ptx) were characterized by particle size and in vitro release. Cytotoxicity, subcellular localization, tumor targeting, and anticancer effect in vivo were investigated respectively. Results: We found that NP-ZnPc(TAP)(4)-Ptx had good stability with qualifying particle size. Interestingly, ZnPc(TAP)(4) was released from the NPs and the photodynamic activity enhanced in the acidic environment of tumor. In addition, NP-ZnPc(TAP)(4)-Ptx had prominent cytotoxicity and time-dependent subcellular localization characteristics. Through a three-dimensional animal imaging system, NP-ZnPc(TAP)(4)-Ptx showed much-enhanced tumor targeting in tumor-bearing mice. Above all, NP-ZnPc(TAP)(4)-Ptx was demonstrated to have the synergistic anticancer effect of PDT and chemotherapy. Conclusion: NP-ZnPc(TAP)(4) Ptx had enhanced tumor targeting for the pH-sensitive property of ZnPc(TAP)(4) and the transport function of HSA. NP-ZnPc(TAP)(4)-Ptx possessed a double-anticancer effect through the combination of ZnPc(TAP)(4) and Ptx. This drug-delivery system may also be used to carry chemotherapy drugs other than Ptx for improving antitumor effects.

Keyword:

antitumor activity chemotherapy combination therapy controlled release drug-delivery system photodynamic therapy

Community:

  • [ 1 ] [Wang, Ying]Qingdao Univ Sci & Technol, Coll Chem Engn, 53 Zhengzhou Rd, Qingdao 266042, Shandong, Peoples R China
  • [ 2 ] [Zheng, Ke]Qingdao Univ Sci & Technol, Coll Chem Engn, 53 Zhengzhou Rd, Qingdao 266042, Shandong, Peoples R China
  • [ 3 ] [Xuan, Guangshan]Qingdao Univ Sci & Technol, Coll Chem Engn, 53 Zhengzhou Rd, Qingdao 266042, Shandong, Peoples R China
  • [ 4 ] [Wang, Ying]Qingdao Univ Sci & Technol, Coll Chem & Mol Engn, Key Lab Inorgan Synthet & Appl Chem, State Key Lab Base Ecochem Engn, Qingdao, Shandong, Peoples R China
  • [ 5 ] [Huang, Mingdong]Fuzhou Univ, Coll Chem, Fuzhou, Fujian, Peoples R China
  • [ 6 ] [Xue, Jinping]Fuzhou Univ, Coll Chem, Fuzhou, Fujian, Peoples R China

Reprint 's Address:

  • [Zheng, Ke]Qingdao Univ Sci & Technol, Coll Chem Engn, 53 Zhengzhou Rd, Qingdao 266042, Shandong, Peoples R China

Show more details

Related Keywords:

Source :

INTERNATIONAL JOURNAL OF NANOMEDICINE

ISSN: 1178-2013

Year: 2018

Volume: 13

Page: 7681-7695

4 . 4 7 1

JCR@2018

6 . 7 0 0

JCR@2023

ESI Discipline: PHARMACOLOGY & TOXICOLOGY;

ESI HC Threshold:161

JCR Journal Grade:1

CAS Journal Grade:2

Cited Count:

WoS CC Cited Count: 19

SCOPUS Cited Count: 20

ESI Highly Cited Papers on the List: 0 Unfold All

WanFang Cited Count:

Chinese Cited Count:

30 Days PV: 2

Online/Total:304/9993918
Address:FZU Library(No.2 Xuyuan Road, Fuzhou, Fujian, PRC Post Code:350116) Contact Us:0591-22865326
Copyright:FZU Library Technical Support:Beijing Aegean Software Co., Ltd. 闽ICP备05005463号-1